A carregar...
Methods for the Construction of Recombinant Oncolytic Myxoma Viruses
Myxoma virus (MYXV) has proven to be an effective candidate for oncolytic virotherapy in many preclinical cancer models. As a nonhuman pathogen, MYXV does not need to overcome any preexisting antiviral immunity, and its DNA cannot integrate into the host genome, making it an extremely safe vector. M...
Na minha lista:
| Publicado no: | Methods Mol Biol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8082691/ https://ncbi.nlm.nih.gov/pubmed/33108657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-0716-1012-1_4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|